Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Alvopetro Announces Q2 2025 Financial Results and an...

Westport

Top 9 Global Lithium Stocks of 2025

Seymour Concentrate Produces Battery Grade Lithium Hydroxide

How to Invest in OpenAI’s ChatGPT

Bitcoin: A Price History of the First Cryptocurrency